These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11834231)

  • 21. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mifepristone 100 mg in abortion regimens.
    Creinin MD; Pymar HC; Schwartz JL
    Obstet Gynecol; 2001 Sep; 98(3):434-9. PubMed ID: 11530125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
    Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
    Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
    Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
    Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
    Reeves MF; Kudva A; Creinin MD
    Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mifepristone followed on the same day by vaginal misoprostol for early abortion.
    Pymar HC; Creinin MD; Schwartz JL
    Contraception; 2001 Aug; 64(2):87-92. PubMed ID: 11704084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.